Cleveland Medical Devices Reports Favorable PTAB Outcomes in Five of Six ResMed IPR Challenges

Cleveland Medical Devices Reports Favorable PTAB Outcomes in Five of Six ResMed IPR Challenges

Cleveland Medical Devices Reports Favorable PTAB Outcomes in Five of Six ResMed IPR Challenges

PR Newswire

CLEVELAND, July 13, 2026

CLEVELAND, July 13, 2026 /PRNewswire/ -- Cleveland Medical Devices Inc. announced that proceedings before the Patent Trial and Appeal Board have now produced favorable outcomes for Cleveland Medical Devices in five of the six inter partes review petitions filed by ResMed against patents involved in the parties' Ohio litigation.

In four of the five proceedings that reached final written decisions, the PTAB determined that ResMed had not established that the challenged claims were unpatentable. In a fifth proceeding, the PTAB denied institution of ResMed's petition. ResMed obtained a favorable final written decision in one proceeding.

"These are important results for Cleveland Medical Devices and its intellectual-property portfolio," said Robert N. Schmidt, Chairman and Chief Executive Officer of Cleveland Medical Devices. "We are pleased that numerous challenged patent claims have survived ResMed's PTAB challenges over the cited prior art."

The PTAB proceedings addressed patentability and did not decide infringement, damages, or other issues pending in the district-court litigations. Cleveland Medical Devices' district-court cases against ResMed remain pending and involve alleged infringement of Cleveland Medical Devices' CPAP and home-sleep-testing patents.

The Ohio PTAB results are separate from Cleveland Medical Devices' pending Delaware litigation involving additional home-sleep-testing patents. Those patents were not involved in the six Ohio IPR proceedings.

Cleveland Medical Devices has 44 patents covering sleep testing and sleep therapy.

Cleveland Medical Devices intends to continue enforcing its intellectual-property rights while respecting all pending judicial and administrative proceedings.

For Further Information Contact:
Robert N. Schmidt, PE, MS, MBA, JD
Founder and Chairman
Cleveland Medical Devices Inc.
216-374-7237
rschmidt@CMDI.biz

View original content to download multimedia:https://www.prnewswire.com/news-releases/cleveland-medical-devices-reports-favorable-ptab-outcomes-in-five-of-six-resmed-ipr-challenges-302824198.html

SOURCE Cleveland Medical Devices Inc.

The articles, information, and content displayed on this webpage may include materials prepared and provided by third parties. Such third-party content is offered for informational purposes only and is not endorsed, reviewed, or verified by Morningstar.

Morningstar makes no representations or warranties regarding the accuracy, completeness, timeliness, or reliability of any third-party content displayed on this site. The views and opinions expressed in third-party content are those of the respective authors and do not necessarily reflect the views of Morningstar, its affiliates, or employees.

Morningstar is not responsible for any errors, omissions, or delays in this content, nor for any actions taken in reliance thereon. Users are advised to exercise their own judgment and seek independent financial advice before making any decisions based on such content. The third-party providers of this content are not affiliated with Morningstar, and their inclusion on this site does not imply any form of partnership, agency, or endorsement.

Popular

Sponsor Center